Fighting mpox: promising vaccines to watch

The World Health Organization declared a global public health emergency as the Mpox virus cases spiked 160% in Africa. Danish biotech Bavarian Nordic is escalating production of Jynneos, the only approved Mpox vaccine. More than 500 deaths have been reported in Africa this year, and the company aims to produce 10 million doses of Jynneos by 2025. Additionally, trials for alternative vaccines are in progress in response to previous Jynneos shortages.